Time and dose dependent effect of indomethacin on BCG induced PMN migration in mice.

The effect of three doses of indomethacin (Indo) on BCG-induced PMN migration at different times of day was studied in Swiss mice kept on a lighting regimen of LD 12:12, with L from 07:00 to 19:00. Experimental granulomas were induced by subcutaneous implantation of BCG-impregnated cell traps for a time span of 480 min. Doses of 1, 3 and 9 mg/kg of Indo were given orally one hour before trap implantation, at 01:00, 05:00, 09:00, 13:00, 17:00 and 21:00 hr. In sham animals, the maximal PMN count occurred at 17:00 hr. In treated mice, Indo increased or decreased the number of PMN/mm2 as a function of time of administration. Cell migration was inhibited at 17:00 hr by all 3 Indo doses, while the number of PMN in the cell trap increased at 21:00 hr. Various dose-effects were obtained at the other times of day. Several hypotheses are proposed to explain the conflicting data. The results indicate the importance of the time of drug administration in biology.     

Possible use of the oxygen uptake rate in the evaluation of BCG vaccines.

Two existing methods suitable for the determination of the oxygen uptake rate (OUR) in BCG suspensions (Warburg and Gilson Oxygraph) are described and compared. With the former method the oxygen uptake rates of the 10 samples of the BCG collaborative assay of the BCG Steering Committee of the International Association of Biological Standardization were determined. When the results are compared with those of colony count and skin reactivity from the collaborative assay, there is a better correlation between OUR and skin reactivity than between OUR and colony count. From the results of our study there is a strong indication that the OUR is a good parameter for quality, and most probably better suited for interlaboratory comparisons than the colony count.     

Evaluation of thermostability of lyophilized BCG vaccines by using an accelerated thermal degradation test]

The degree of thermal degradation of BCG vaccines prepared from various substrains, using a test evaluating number of viable particles of BCG was determined. Thermal degradation coefficient were established for particular vaccines in different temperatures and a prognosis time curve of 50% CFU titer loss was constructed. It was found, that polish vaccine does not differ essentially from danish and french vaccines in respect to thermostability. Japanese preparation showed higher stability in all temperatures tested as compared to above mentioned vaccines. It was shown that when based on presented figures, and using interpolation method, it is possible with a high degree of probability foresee a decrease of vaccine titer at optional temperature.     

Evaluation of the neurovirulence test for mumps vaccines.

Neurovirulence tests in Macaca fascicularis using commercial preparations of different vaccine bulks and a wild-type strain revealed that the test was unable to distinguish mixed from pure populations or a suitable vaccine from a related strain which has been shown to be associated with clinical meningitis. However, the test was able to distinguish a wild-type strain from the vaccine strains successfully. The ability of the test to discriminate between acceptable and unacceptable seeds requires further examination.     

The role of the BCG dose and the mouse strain in the inhibition of development of neoplasms susceptible and nonsusceptible to the action of natural cytotoxic cells

The susceptibility of Ehrlich Ascites Carcinoma (EAC) cells to the action of natural cytotoxic cells of DBA/2 and Balb/c mice in vitro was established. Leukaemia L 1210 cells proved insensitive to the in vitro action of natural cytotoxic cells of DBA/2 mice, but not to those of Balb/c ones. BCG, one of the inductors of cytotoxic NK cells, when administered to DBA/2 or Balb/c mice before introduction of EAC cells inhibited the growth of this tumour but did not retard the development of leukaemia L 1210 in DBA/2 mice. The change in the number of peritoneal exsudate cells (PEC) in DBA/2 mice after intraperitoneal injection of BCG was demonstrated to be dependent on the dose and the time elapsed after bacilli introduction. The antitumour action of BCG does not depend on changes in the number of PEC caused by the bacilli. Both large (3.0 mg) and small (0.02 mg) doses of BCG inhibit the development of EAC in Balb/c mice ("sensitive" to BCG), notwithstanding the time of administration of the bacilli. In DBA/2 mice ("resistant" to BCG) development of EAC can be inhibited only by the large dose of BCG since small one is sometimes ineffective.